Mesoblast (MESO) Assets (2015 - 2025)
Mesoblast's (MESO) quarterly Assets came in at $782.3 million in Q4 2025, up 19.74% year-on-year from $653.3 million in Q4 2024, and little changed quarter-over-quarter from $784.7 million in Q2 2025.
Mesoblast (MESO) Assets (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Assets across 11 years of filings, most recently posting $782.3 million for Q4 2025.
- Assets for Q4 2025 came in at $782.3 million, up 19.74% year-over-year; the trailing twelve-month figure through Dec 2025 was $782.3 million (up 19.74% YoY), and the FY2025 annual result was $784.7 million, up 17.27% from the prior year.
- Assets came in at $782.3 million for Q4 2025 at Mesoblast, roughly flat from $784.7 million in the prior quarter.
- In the past five years, Assets ranged from a high of $784.7 million in Q2 2025 to a low of $650.4 million in Q1 2023.
- The 5-year median for Assets is $681.7 million (2022), against an average of $700.9 million.
- Across the five-year window, Assets dropped 11.09% in 2022 and rose 19.74% in 2025, its largest moves.
- Mesoblast's Assets stood at $704.4 million in 2021, then slipped by 5.16% to $668.1 million in 2022, then increased by 0.33% to $670.3 million in 2023, then slipped by 2.53% to $653.3 million in 2024, then climbed by 19.74% to $782.3 million in 2025.
- The last three Assets figures came in at $782.3 million (Q4 2025), $784.7 million (Q2 2025), and $653.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 782.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 782.31 Mn |
| Jun 30, 2025 | 784.68 Mn |
| Dec 31, 2024 | 653.32 Mn |
| Jun 30, 2024 | 669.15 Mn |
| Dec 31, 2023 | 670.29 Mn |
| Jun 30, 2023 | 669.42 Mn |
| Mar 31, 2023 | 650.44 Mn |
| Dec 31, 2022 | 668.06 Mn |
| Sep 30, 2022 | 684.50 Mn |
| Jun 30, 2022 | 662.14 Mn |
| Mar 31, 2022 | 681.69 Mn |
| Dec 31, 2021 | 704.44 Mn |
| Sep 30, 2021 | 721.82 Mn |
| Jun 30, 2021 | 744.72 Mn |
| Mar 31, 2021 | 766.13 Mn |
| Dec 31, 2020 | 687.31 Mn |
| Sep 30, 2020 | 712.57 Mn |
| Jun 30, 2020 | 733.60 Mn |
| Mar 31, 2020 | 665.79 Mn |
| Dec 31, 2019 | 690.24 Mn |